These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8444658

  • 1. Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin.
    Sett R, Sarkar HS, Das PK.
    J Antimicrob Chemother; 1993 Jan; 31(1):151-9. PubMed ID: 8444658
    [Abstract] [Full Text] [Related]

  • 2. Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis.
    Chakraborty P, Bhaduri AN, Das PK.
    Biochem Biophys Res Commun; 1990 Jan 15; 166(1):404-10. PubMed ID: 2302213
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K, Das PK.
    J Immunol; 1997 Jun 01; 158(11):5357-65. PubMed ID: 9164956
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of mannose receptors on macrophages after infection with Leishmania donovani.
    Basu N, Sett R, Das PK.
    Biochem J; 1991 Jul 15; 277 ( Pt 2)(Pt 2):451-6. PubMed ID: 1859373
    [Abstract] [Full Text] [Related]

  • 6. Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease.
    Sett R, Sarkar K, Das PK.
    J Infect Dis; 1993 Oct 15; 168(4):994-9. PubMed ID: 8376846
    [Abstract] [Full Text] [Related]

  • 7. Overexpressed Macrophage Mannose Receptor Targeted Nanocapsules- Mediated Cargo Delivery Approach for Eradication of Resident Parasite: In Vitro and In Vivo Studies.
    Asthana S, Gupta PK, Jaiswal AK, Dube A, Chourasia MK.
    Pharm Res; 2015 Aug 15; 32(8):2663-77. PubMed ID: 25715698
    [Abstract] [Full Text] [Related]

  • 8. Receptor-mediated endocytosis of fucosylated neoglycoprotein by macrophages.
    Sarkar K, Sarkar HS, Kole L, Das PK.
    Mol Cell Biochem; 1996 Mar 23; 156(2):109-16. PubMed ID: 9095466
    [Abstract] [Full Text] [Related]

  • 9. Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins.
    Han J, Lim SJ, Lee MK, Kim CK.
    Drug Deliv; 2001 Mar 23; 8(3):125-34. PubMed ID: 11570592
    [Abstract] [Full Text] [Related]

  • 10. Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics.
    Hirata K, Maruyama T, Watanabe H, Maeda H, Nakajou K, Iwao Y, Ishima Y, Katsumi H, Hashida M, Otagiri M.
    J Control Release; 2010 Jul 01; 145(1):9-16. PubMed ID: 20304018
    [Abstract] [Full Text] [Related]

  • 11. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N, Mukherjee S, Das L, Das PK.
    Eur J Immunol; 2003 Jun 01; 33(6):1508-18. PubMed ID: 12778468
    [Abstract] [Full Text] [Related]

  • 12. Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.
    Chaurasia M, Singh PK, Jaiswal AK, Kumar A, Pawar VK, Dube A, Paliwal SK, Chourasia MK.
    Pharm Res; 2016 Nov 01; 33(11):2617-29. PubMed ID: 27401407
    [Abstract] [Full Text] [Related]

  • 13. Receptor-mediated entry of beta-glucuronidase into the parasitophorous vacuoles of macrophages infected with Leishmania mexicana amazonensis.
    Shepherd VL, Stahl PD, Bernd P, Rabinovitch M.
    J Exp Med; 1983 May 01; 157(5):1471-82. PubMed ID: 6304225
    [Abstract] [Full Text] [Related]

  • 14. Selective delivery of drugs to macrophages through a highly specific receptor. An efficient chemotherapeutic approach against leishmaniasis.
    Chaudhuri G, Mukhopadhyay A, Basu SK.
    Biochem Pharmacol; 1989 Sep 15; 38(18):2995-3002. PubMed ID: 2783154
    [Abstract] [Full Text] [Related]

  • 15. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
    Afzal I, Sarwar HS, Sohail MF, Varikuti S, Jahan S, Akhtar S, Yasinzai M, Satoskar AR, Shahnaz G.
    Nanomedicine (Lond); 2019 Feb 15; 14(4):387-406. PubMed ID: 30688557
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles.
    Jain S, Mathur R, Das M, Swarnakar NK, Mishra AK.
    Nanomedicine (Lond); 2011 Dec 15; 6(10):1733-54. PubMed ID: 22087800
    [Abstract] [Full Text] [Related]

  • 17. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells.
    Higuchi Y, Nishikawa M, Kawakami S, Yamashita F, Hashida M.
    Int J Pharm; 2004 Dec 09; 287(1-2):147-54. PubMed ID: 15541921
    [Abstract] [Full Text] [Related]

  • 18. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H, Hockertz S.
    Arzneimittelforschung; 1999 Nov 09; 49(11):954-61. PubMed ID: 10604050
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ.
    Clin Cancer Res; 2003 May 09; 9(5):1917-26. PubMed ID: 12738750
    [Abstract] [Full Text] [Related]

  • 20. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.
    Kamps JA, Morselt HW, Swart PJ, Meijer DK, Scherphof GL.
    Proc Natl Acad Sci U S A; 1997 Oct 14; 94(21):11681-5. PubMed ID: 9326670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.